Results 1 to 10 of about 29 (21)

Viburcol, Engystol, Lymphomyosot — Bioregulatory Approach in Pediatric Practice

open access: yesZdorovʹe Rebenka, 2016
One of the most urgent problems in modern pediatrics and neonatology is the need for drugs, which, along with proven efficacy, also will be maximum safe for a growing child’s body. The article presents an overview of publications on clinical studies of combined bioregulatory drugs (CBD) ­Viburcol, Engystol, Lymphomyosot, Lymphomyosot H by German ...
S.V. Popovych
doaj   +7 more sources

Viburcol — Bioregulatory Approach in Childhood Diseases

open access: yesZdorovʹe Rebenka, 2015
One of the most urgent problems of modern pediatrics and neonatology is a need for drugs, which, along with proven efficacy, also will have maximal safety for a growing child’s body. This is due to pediatricians, family doctors, narrowly focused pediatric specialists face the fact that highly effective drugs also have a negative impact on the child’s ...
S.V. Popovich
doaj   +4 more sources

Respiratory viral infections: approaches to therapy from the perspective of clinical and pathogenetic aspects of the disease [PDF]

open access: yesМедицинский совет, 2022
Introduction. Acute respiratory viral infections in children remain an urgent problem, not only because of the high incidence, but also a significant contribution to the mortality structure of young children.
G. V. Santalova, S. V. Plakhotnikova
doaj   +3 more sources

Experience of using a complex bioregulatory drug in young children [PDF]

open access: yesМедицинский совет, 2021
Introduction. The paper presents modern insights into the pathogenesis and role of inflammatory reactions in the developmentof the respiratory pathology.
Khakim M. Vakhitov   +2 more
doaj   +3 more sources
Some of the next articles are maybe not open access.

Efficacy and safety assessment of viburcol drug for preparation of uterine cervix for childbirth and prevention of labor anomalies

HEALTH OF WOMAN, 2016
The objective is to compare the effectiveness of complex bio-regulatory medication (CBRM) Viburcol, produced by «Biologishe Haylmittel Heel GmbH», Germany, with the reference product No-X-sha, produced by «Lekhim-Kharkov», which are used as antispasmodics, for preparation of uterine cervix for childbirth and prevention of labor anomalies. Patients and
Avramenko, T. V., Moschich, A. P.
openaire   +2 more sources

THE USE OF VIBURCOL® FOR TEETHING

DRUGS AND RATIONAL PHARMACOTHERAPY
Abstract. This case shows a clinical example of the successful use of the drug Viburcol® during teething in a child. Thanks to the use of this drug, it was possible to quickly relieve symptoms such as irritability and loss of appetite due to teething.
openaire   +1 more source

THE USING OF VIBURCOL® FOR ARVI DURING DENTING IN AN INFANT

DRUGS AND RATIONAL PHARMACOTHERAPY
Acute respiratory viral infections (ARVI) in infants, especially with concomitant denting, pose a complex diagnostic and therapeutic challenge for pediatricians. The presented clinical case describes the observation of a patient 6 months old with ARVI and acute nasopharyngitis developed against the background of teething.
openaire   +1 more source

THE TEETHING SYNDROME IN INFANTS: CLINICAL EXPERIENCE WITH THE USE OF VIBURCOL®

DRUGS AND RATIONAL PHARMACOTHERAPY
A clinical case study of the use of Viburcol® for teething syndrome is presented. Viburcol® suppositories effectively relieved the symptoms of teething syndrome, allowing the child and parents to get through this period safely.
openaire   +1 more source

THE USE OF VIBURCOL® FOR ACUTE RESPIRATORY VIRAL INFECTION IN CHILDREN

DRUGS AND RATIONAL PHARMACOTHERAPY
In this clinical example, the use of Viburcol® in a 2-year-old girl with acute nasopharyngitis is considered. The patient was admitted with complaints of low-grade fever, runny nose, lethargy and moodiness. As part of the complex therapy, Viburcol® rectal suppositories were prescribed 2 times a day for 5 days.
openaire   +1 more source

Home - About - Disclaimer - Privacy